Steele, Christopher D;
Pillay, Nischalan;
Alexandrov, Ludmil B;
(2022)
An overview of mutational and copy number signatures in human cancer.
Journal of Pathology
, 257
(4)
pp. 454-465.
10.1002/path.5912.
Preview |
Text
The Journal of Pathology - 2022 - Steele - An overview of mutational and copy number signatures in human cancer.pdf Download (4MB) | Preview |
Abstract
The genome of each cell in the human body is constantly under assault from a plethora of exogenous and endogenous processes that can damage DNA. If not successfully repaired, DNA damage generally becomes permanently imprinted in cells, and all their progenies, as somatic mutations. In most cases, the patterns of these somatic mutations contain the tell-tale signs of the mutagenic processes that have imprinted and are termed mutational signatures. Recent pan-cancer genomic analyses have elucidated the compendium of mutational signatures for all types of small mutational events, including: (i) single base substitutions; (ii) doublet base substitutions; and (iii) small insertions/deletions. In contrast to small mutational events, where, in most cases, DNA damage is a prerequisite, aneuploidy, which refers to the abnormal number of chromosomes in a cell, usually develops from mistakes during DNA replication. Such mistakes include DNA replication stress, mitotic errors caused by faulty microtubule dynamics, or cohesion defects that contribute to chromosomal breakage and can lead to copy number alterations or even to structural rearrangements. These aberrations also leave behind genomic scars which can be inferred from sequencing as copy number signatures and rearrangement signatures. The analyses of mutational signatures of small mutational events have been extensively reviewed [1-3], so we will not comprehensively re-examine them here. Rather, our focus will be on summarizing the existing knowledge for mutational signatures of copy number alterations. As studying copy number signatures is an emerging field, we briefly summarize the utility that mutational signatures of small mutational events have provided in basic science, cancer treatment, and cancer prevention and we emphasize the future role that copy number signatures may play in each of these fields.
| Type: | Article |
|---|---|
| Title: | An overview of mutational and copy number signatures in human cancer |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/path.5912 |
| Publisher version: | https://doi.org/10.1002/path.5912 |
| Language: | English |
| Additional information: | Copyright © 2022 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Keywords: | cancer, copy number signatures, genomics, mutational signatures |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10147099 |
Archive Staff Only
 |
View Item |
